This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Haemonetics Corporation. Active years: 2013-2014.
Company Filing History:
Years Active: 2013-2014
Title: Innovations by Pascal Maillard in Plasma Reduced Platelet Collection
Introduction
Pascal Maillard is an accomplished inventor based in Crassier, Switzerland. He has made significant contributions to the field of medical technology, particularly in the area of platelet collection. With a total of 2 patents to his name, Maillard's work focuses on improving the efficiency and effectiveness of blood component collection.
Latest Patents
One of Pascal Maillard's latest patents is a system and method for plasma reduced platelet collection. This innovative method and apparatus are designed to collect plasma reduced platelets that may be suspended in a synthetic solution from a donor. The process begins with drawing whole blood from the donor, which is then introduced into a separation chamber. Platelets are extracted from this chamber into a container using surge or push methodologies. The remaining blood components are returned to the donor, and the steps of drawing blood, extracting platelets, and returning components are repeated. Ultimately, the sequestered platelets are reintroduced into the separation chamber, allowing for the extraction of a plasma reduced platelet product.
Career Highlights
Pascal Maillard is currently associated with Haemonetics Corporation, a company known for its innovative solutions in blood management. His work at Haemonetics has been pivotal in advancing technologies that enhance patient care and improve the efficiency of blood collection processes.
Collaborations
Throughout his career, Maillard has collaborated with notable professionals in the field, including Toshiyasu Ohashi and Etienne Pagès. These collaborations have contributed to the development of cutting-edge technologies in blood component collection.
Conclusion
Pascal Maillard's contributions to the field of medical technology, particularly in plasma reduced platelet collection, highlight his innovative spirit and dedication to improving healthcare solutions. His patents and work at Haemonetics Corporation continue to influence the industry positively.